Health Economic Analysis of Automated Insulin Delivery Systems

Safely administering insulin to manage blood glucose is challenging for people with type 1 diabetes (T1D). Artificial pancreas or automated insulin delivery (AID) systems mimic pancreatic function by measuring blood glucose (using real-time continuous glucose monitoring), calculating insulin requirements, and automatically delivering insulin via an insulin pump. This study will determine if AID systems provide good value compared with standard insulin delivery. We will support the external validation of a computer simulation model (Swedish National Diabetes Register T1D model) which will then be used to estimate the long-term cost-effectiveness (from the US health care system and payer perspective) of AID systems compared with standard therapy among T1D patients. This is a collaboration among DOR, University of Michigan, Jaeb Center for Health Research, and University of Oxford.

0